ESR1 and breast cancer: Genetic variations in MIR2052HG were associated with the BC-free interval in the MA.27 trial (ClinicalTrials.gov number NCT00066573), and the variant SNPs were associated with increased MIR2052HG expression due to increased ERα binding to EREs [17, 25].